MoonLake Immunotherapeutics

Q2 2022 13F Holders

Symbol: MLTX
CUSIP: 61559X104
Type: Equity
Class: CLASS A ORD
Num filings: 24
Total reported value, excl. options: $190 M

Compare 2022 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type